Amarin Asks Fed. Circ. To Undo Heart Drug IP Decision
By Adam Lidgett ( March 22, 2023, 7:42 PM EDT) -- Amarin Pharma Inc. has asked the Federal Circuit to reverse a Delaware federal judge's finding that Hikma Pharmaceuticals USA Inc.'s generic heart drug does not infringe patents underlying Amarin drug Vascepa....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.